Susquehanna International Group’s Putnam BioRevolution ETF SYNB Stock Holding History

Susquehanna International Group’s Portfolio SYNB Stock Details SYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,931	Closed	-$357K	–	13592
2025 Q3	$357K	Buy	+11,931	New	+$353K	﹤0.01%	9719

Susquehanna International Group's SYNB Position: Q4 2025 in Review

Susquehanna International Group sold out of Putnam BioRevolution ETF (SYNB) in Q4 2025, closing a stake of 11,931 shares — an estimated $357K sold.

Susquehanna International Group first reported a position in SYNB in Q3 2025 and held it in 1 quarter. The position peaked at $357K in Q3 2025. 0 funds tracked by Wall St. Rank hold SYNB as of Q4 2025.

Susquehanna International Group reported no remaining Putnam BioRevolution ETF position as of Q4 2025 after selling out during the quarter.
Susquehanna International Group sold 11,931 Putnam BioRevolution ETF shares in Q4 2025, an estimated $357K.
Susquehanna International Group first reported a position in Putnam BioRevolution ETF in Q3 2025 and held it in 1 quarter.
Susquehanna International Group's Putnam BioRevolution ETF position peaked at $357K in Q3 2025.
0 funds tracked by Wall St. Rank held Putnam BioRevolution ETF as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.